BioMarin Grant

The BioMarin Grant aims to support events, activities, and projects that enhance public health and benefit patients with rare diseases. This corporate funder focuses on scientific innovation and provides resources for organizations such as hospitals, universities, and patient advocacy groups. With an emphasis on education and community support, BioMarin encourages applications for funding throughout the year, ensuring timely assistance for eligible projects.

NOTE:  This grant is only featuring the North American Region. Funding requests are accepted for review all year. Due to BioMarin’s year-end close out activities, all requests requiring funding prior to year-end must be submitted on or before the deadline.
United States (US): We ask for a minimum of 60 days prior to a given event to accommodate time for review by our committee and processing of the funding.Canada & Europe: We ask for a minimum of 60 days prior to a given event to accommodate time for review by our committee and processing of the funding.
Grants provide funding for a variety of events, activities, and projects that benefit patients, the scientific or medical community, and/or public health in areas of legitimate interest to BioMarin.
Areas of Focus
BioMarin is a multinational Biotechnology company that develops and globally markets innovative therapeutics to patients with rare diseases who have serious unmet medical needs.
BioMarin is a world leader in developing and commercializing innovative biopharmaceuticals for rare diseases driven by genetic causes. At BioMarin, we focus on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases. BioMarin remains steadfast to its original mission—to bring new treatments to market that will make a big impact on small patient populations.
BioMarin is committed to patients, families, and physicians in providing rapid access to treatments, disease education, and support services.
As part of its commitment, BioMarin supports programs and activities that foster excellences in patient care and provide valuable scientific, medical, and educational information to the medical and scientific communities as well as patient advocacy organizations.
In alignment with BioMarin’s commitment to scientific innovation and addressing areas of unmet medical needs, BioMarin supports donations and grants in the following areas:

• Rare Disease (Generally)
• Mucopolysaccharidosis (MPS)
• Phenylketonuria (PKU)
• CLN2 (Batten Disease)
• Achondroplasia
• Hemophilia
• Community Relations Giving

Eligibility

The following types of organizations are eligible to submit requests for Medical Education, Donation or Grant funding:Accredited providers
Community projects or groups
Registered CharitiesGrant requests for accredited activities must be submitted by an accredited provider, even if jointly sponsored by a Medical Education Company.

Ineligibility

We do not accept grant requests from individuals, including individual physicians or groups of physicians in private practice.Per company policy, where funding is requested for a specific event or activity, BioMarin is unable to accept the request where the program date has passed.BioMarin will deny, without consideration, any grant request submitted by an organization named on a debarment or exclusion list, including, but not limited to, the U.S. Office of Inspector General’s List of Excluded Individuals/Entities (OIG LEIE) or the U.S. General Services Administration Excluded Parties List System (GSA EPLS).